Overview

Neoadjuvant Taxotere

Status:
Completed

Trial end date:
2004-07-01

Target enrollment:

Participant gender:

Summary

The purposes of this study are to better understand how Taxotere causes tumors to become smaller and to find out how effective Taxotere is in treating the type of breast cancer that you have.

Phase:

Phase 2

Details

Lead Sponsor:

Baylor Breast Care Center

Collaborator:

Aventis Pharmaceuticals

Treatments:

Docetaxel